BioSpace News Archive

Drug Development

IntelGenx Receives Health Canada Clearance to Begin Phase IIa Study With Montelukast Versafilm in Mild to Moderate Alzheimer’s Disease

The phase 2a proof of concept clinical study will start screening AD patients in Q1 2018.

December 15, 2017
·
4 min read
Deals

Wright Medical Takes Out Surgery Planning Software Dev. IMASCAP in $89M Deal

The transaction ensures exclusive access to breakthrough software enabling tech and patents to further differentiate Wright’s product portfolio.

December 15, 2017
·
12 min read
BioCapital

GlycoMimetics Added To NASDAQ Biotechnology Index

The annual re-ranking of the NASDAQ Biotechnology Index will be effective prior to market upon on Monday, December 18, 2017.

December 15, 2017
·
1 min read
Teva Announces Exclusive Launch of Generic Viread in the United States

Teva announced the exclusive launch of generic Viread1 (tenofovir disoproxil fumarate) tablets 300 mg in the U.S.

December 15, 2017
·
9 min read
Biotech Bay

Bay Area’s Global Blood Therapeutics Prices a $100M Common Stock Public Offering

Cantor Fitzgerald & Co. is the sole book-running manager for the offering.

December 15, 2017
·
5 min read
Pharm Country

RespireRx Pharmaceuticals Officers and Directors Elect to Forgive $2,356,733 of Past Due Cash Compensation and Receive Non-Qualified Stock Options to Reduce Balance Sheet Debt

The Amendment increases the shares issuable under the plan by 3,946,799, from 3,038,461 shares to 6,985,260.

December 15, 2017
·
9 min read
Business

Tikcro Technologies Reports Third Quarter 2017 Results

Tikcro Technologies today reported its financial results for the third quarter ended September 30, 2017.

December 15, 2017
·
6 min read
BioMidwest

PolarityTE Announces Application of SkinTE on First Patients

SkinTE is applied to a variety of indications and wounds.

December 15, 2017
·
5 min read
Genetown

Tetraphase Pharma Added to NASDAQ Biotechnology Index

The annual re-ranking of the NASDAQ Biotechnology Index will become effective prior to U.S. market open on Monday, December 18, 2017.

December 15, 2017
·
1 min read
Biotech Bay

Galena Will Adjourn Special Meeting Until Friday, December 29, 2017, Urges Stockholders to Vote

The Proxy Statement/Prospectus/Consent Solicitation Statement was previously supplemented by a supplement dated November 29, 2017 and filed with the SEC pursuant to Rule 424(b)(3) on November 30, 2017.

December 15, 2017
·
4 min read